The partnership could help increase the volume of referrals to Dana-Farber, which currently draws about 70 percent of its patient population from Massachusetts. It would also expand the pool from which Dana-Farber clinicians conduct clinical studies, according to the report.
The cancer center began a similar partnership with Portland-based MaineHealth, the largest healthcare provider in Maine, in December as part of an effort to expand its market share across New England, according to the report.
Lifespan’s CEO, Timothy J. Babineau, MD, said partnering with Dana-Farber will enable Lifespan to retain patients who currently seek cancer care outside of the state. Roughly 13 percent of cancer patients in Rhode Island seek care outside of the state.
“This will help patients of Rhode Island know if they come here, they will have the added expertise of the Dana-Farber,” said Dr. Babineau.
More articles on affiliations:
Carolinas HealthCare organizes CIN
St. Elizabeth strikes deal with 38-physician Cincinnati medical group
Amedisys to acquire Associated Home Care
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.